- Home
- REE vs IPSC Comparison
REE vs IPSC Comparison
Compare REE & IPSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REE
- IPSC
- Stock Information
- Founded
- REE 2011
- IPSC 2019
- Country
- REE Israel
- IPSC United States
- Employees
- REE N/A
- IPSC N/A
- Industry
- REE Auto Manufacturing
- IPSC Medicinal Chemicals and Botanical Products
- Sector
- REE Consumer Discretionary
- IPSC Health Care
- Exchange
- REE Nasdaq
- IPSC Nasdaq
- Market Cap
- REE 67.1M
- IPSC 58.1M
- IPO Year
- REE N/A
- IPSC 2021
- Fundamental
- Price
- REE $2.51
- IPSC $0.54
- Analyst Decision
- REE Strong Buy
- IPSC Strong Buy
- Analyst Count
- REE 3
- IPSC 5
- Target Price
- REE $12.50
- IPSC $3.67
- AVG Volume (30 Days)
- REE 221.0K
- IPSC 551.0K
- Earning Date
- REE 05-29-2025
- IPSC 05-08-2025
- Dividend Yield
- REE N/A
- IPSC N/A
- EPS Growth
- REE N/A
- IPSC N/A
- EPS
- REE N/A
- IPSC N/A
- Revenue
- REE $626,000.00
- IPSC $6,589,000.00
- Revenue This Year
- REE N/A
- IPSC $833.10
- Revenue Next Year
- REE $21,152.58
- IPSC N/A
- P/E Ratio
- REE N/A
- IPSC N/A
- Revenue Growth
- REE N/A
- IPSC 194.81
- 52 Week Low
- REE $2.35
- IPSC $0.34
- 52 Week High
- REE $11.72
- IPSC $3.70
- Technical
- Relative Strength Index (RSI)
- REE 28.92
- IPSC 53.48
- Support Level
- REE $2.31
- IPSC $0.34
- Resistance Level
- REE $2.90
- IPSC $0.54
- Average True Range (ATR)
- REE 0.33
- IPSC 0.05
- MACD
- REE 0.13
- IPSC 0.02
- Stochastic Oscillator
- REE 23.28
- IPSC 93.95
About REE REE Automotive Ltd.
REE Automotive Ltd is an automotive technology company focused on building commercial electric vehicles controlled fully by-wire. The company is developing REEcorner technology which packs critical vehicle components into a single compact module positioned between the chassis and the wheel as well as building commercial Electric Vehicles (EV) leveraging REEcorner technology. The company has geographical preference in Israel, Germany, United States, United Kingdom, and other regions.
About IPSC Century Therapeutics Inc.
Century Therapeutics Inc is a biotechnology company specializes in leveraging adult stem cells to develop advanced cell therapy products targeting cancer, autoimmune, and inflammatory diseases. Their innovative approach involves a genetically engineered allogeneic cell therapy platform comprising induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and cutting-edge manufacturing capabilities. This comprehensive platform aims to overcome the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and minimizing development and supply risks.